PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA

被引:1253
作者
Adasme, Melissa F. [1 ]
Linnemann, Katja L. [1 ]
Bolz, Sarah Naomi [1 ]
Kaiser, Florian [2 ]
Salentin, Sebastian [1 ]
Haupt, V. Joachim [2 ]
Schroeder, Michael [1 ]
机构
[1] Tech Univ Dresden, CMCB, Biotechnol Ctr BIOTEC, Tatzberg 47-49, D-01307 Dresden, Germany
[2] PharmAI GmbH, D-01307 Dresden, Germany
关键词
ESTROGEN RESPONSE ELEMENT; ANTITUMOR-ACTIVITY; XR5944; MLN944; PHASE; INTERCALATION; TRANSCRIPTION; RECOGNITION; COMBINATION;
D O I
10.1093/nar/gkab294
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the growth of protein structure data, the analysis of molecular interactions between ligands and their target molecules is gaining importance. PLIP, the protein-ligand interaction profiler, detects and visualises these interactions and provides data in formats suitable for further processing. PLIP has proven very successful in applications ranging from the characterisation of docking experiments to the assessment of novel ligand-protein complexes. Besides ligand-protein interactions, interactions with DNA and RNA play a vital role in many applications, such as drugs targeting DNA or RNA-binding proteins. To date, over 7% of all 3D structures in the Protein Data Bank include DNA or RNA. Therefore, we extended PLIP to encompass these important molecules. We demonstrate the power of this extension with examples of a cancer drug binding to a DNA target, and an RNA-protein complex central to a neurological disease. PLIP is available online at https://plip-tool.biotec.tu-dresden.de and as open source code. So far, the engine has served over a million queries and the source code has been downloaded several thousand times.
引用
收藏
页码:W530 / W534
页数:5
相关论文
共 38 条
[1]  
[Anonymous], 2007, MOL BIOL CELL
[2]   Mechanisms and Consequences of Macromolecular Phase Separation [J].
Bergeron-Sandoval, Louis-Philippe ;
Safaee, Nozhat ;
Michnick, Stephen W. .
CELL, 2016, 165 (05) :1067-1079
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Protein Phase Separation: A New Phase in Cell Biology [J].
Boeynaems, Steven ;
Alberti, Simon ;
Fawzi, Nicolas L. ;
Mittag, Tanja ;
Polymenidou, Magdalini ;
Rousseau, Frederic ;
Schymkowitz, Joost ;
Shorter, James ;
Wolozin, Benjamin ;
Van den Bosch, Ludo ;
Tompa, Peter ;
Fuxreiter, Monika .
TRENDS IN CELL BIOLOGY, 2018, 28 (06) :420-435
[5]   The antiproliferative agent MLN944 preferentially inhibits transcription [J].
Byers, SA ;
Schafer, B ;
Sappal, DS ;
Brown, J ;
Price, DH .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (08) :1260-1267
[6]   2D depiction of protein - Ligand complexes [J].
Clark, Alex M. ;
Labute, Paul .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (05) :1933-1944
[7]   Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug [J].
Dai, JX ;
Punchihewa, C ;
Mistry, P ;
Ooi, AT ;
Yang, DZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :46096-46103
[8]   PDBsum additions [J].
de Beer, Tjaart A. P. ;
Berka, Karel ;
Thornton, Janet M. ;
Laskowski, Roman A. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) :D292-D296
[9]   BINANA: A novel algorithm for ligand-binding characterization [J].
Durrant, Jacob D. ;
McCammon, J. Andrew .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2011, 29 (06) :888-893
[10]   Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 [J].
Elfiky, Abdo A. .
LIFE SCIENCES, 2020, 248